Indications actuelles de l’imagerie hybride TEP-IRM corps entier
Author:
Vermersch Mathilde
Reference43 articles.
1. Chan SC, Yeh CH, Yen TC, et al. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 2018 ; 45(8) : 1297308.
2. Katirtzidou E, Rager O, Varoquaux AD, et al. Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma : comparison of [18F]FDG PET/MRI and [18F]FDG PET/CT. Insights Imaging 2022 ; 13(1) : 121.
3. Murtojärvi S, Malaspina S, Kinnunen I, et al. Diagnostic accuracy of 18F-FDG-PET/CT and 18F-FDG-PET/MRI in detecting locoregional recurrence of HNSCC 12 weeks after the end of chemoradiotherapy : single-center experience with PET/MRI. Contrast Media Mol Imaging 2022 ; 2022 : 8676787.
4. Wang F, Guo R, Zhang Y, et al. Value of 18F-FDG PET/MRI in the preoperative assessment of resectable esophageal squamous cell carcinoma : a comparison with 18F-FDG PET/CT, MRI, and contrast-enhanced CT. Front Oncol 2022 ; 12 : 844702.
5. Catalano OA, Lee SI, Parente C, et al. Improving staging of rectal cancer in the pelvis : the role of PET/MRI. Eur J Nucl Med Mol Imaging 2021 ; 48(4) : 123545.